Neurology
1 drug is in development for Polyneuropathies.
- Companies
- 1
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Polyneuropathies pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| nexiguran ziclumeran | Intellia Therapeutics, Inc. (NTLA) |
About this indication
Polyneuropathies context
Neurology·MeSH: Polyneuropathies (D011115)
Also known as: Polyneuropathy
Frequently asked questions
How many drugs are in development for Polyneuropathies?
BioSniper tracks 1 drug in development for Polyneuropathies across 1 company.
How many clinical trials target Polyneuropathies?
There are 5 clinical trials targeting Polyneuropathies tracked by BioSniper.